Mercado de citocinas GMP: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00008212
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 145
Buy Now

El mercado de citocinas GMP se valoró en 84,72 millones de dólares estadounidenses en 2019 y se estima que crecerá a una tasa compuesta anual del 8,1 % de 2020 a 2027.

GMP Las citocinas se utilizan en terapia celular y genética para la expansión y diferenciación de diversos tipos de células, cultivos ex vivo y otros enfoques terapéuticos. Además, se utilizan en diversos productos de ingeniería de tejidos para aplicaciones clínicas. Además, se están realizando investigaciones exhaustivas sobre las citocinas para descubrir nuevos enfoques terapéuticos para tratar enfermedades crónicas. El crecimiento del mercado de citocinas GMP se atribuye principalmente a factores como el aumento de la aceptación de las citocinas contra el cáncer y las terapias autoinmunes, y la contribución potencial en la terapia con células madre. Sin embargo, se prevé que el alto costo asociado con la terapia con citocinas GMP disuade el crecimiento del mercado.

regiones lucrativas para el mercado de citocinas GMP


Perspectivas del mercado

Creciente aceptación de las citocinas para el cáncer y las terapias autoinmunes

Las citocinas desempeñan un papel importante en la regulación de la inmunidad innata y adaptativa, que permite que las células del sistema inmunológico para comunicarse en distancias cortas. La terapia con citoquinas para activar el sistema inmunológico de los pacientes con cáncer ha sido un parámetro esencial en el tratamiento del cáncer y continúa siendo un importante contribuyente a la investigación clínica actual sobre el cáncer. El interferón alfa es una de las citocinas aprobadas para el tratamiento adyuvante de neoplasias malignas refractarias. Varias actividades de investigación han demostrado la capacidad de las citocinas para limitar el crecimiento de las células tumorales mediante una actividad antiproliferativa o proapoptótica directa. Además, algunas citoquinas inhiben indirectamente el crecimiento del tumor al estimular la actividad citotóxica de las células inmunes contra las células tumorales. Es probable que esta eficacia de las terapias con citoquinas sobre el cáncer, junto con la creciente prevalencia de la enfermedad, impulse el mercado para 2027. Según la Organización Mundial de la Salud, en 2019, aproximadamente 9,6 millones de muertes en todo el mundo se debieron al cáncer.

Europa

  • Francia
  • Alemania
  • Italia
  • Reino Unido
  • España
  • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • Sur y Centroamérica
    • Brasil
    • Argentina
    • Resto de Sudamérica y Centroamérica
  •   ;

    Perfiles de la empresa

    • Miltenyi Biotec
    • Sino Biological Inc.
    • ABCAM
    • PeproTech Inc
    • Akron Biotech
    • CellGenix GmbH
    • BIO-TECHNE CORPORATION
    • CREATIVE BIOARRAY
    • Proteintech Group Inc.
    • REPROCELL Inc
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are GMP cytokines?

    GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures and other therapeutic approaches. Moreover, these are also used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions

    What are the driving factors for the GMP cytokines market across the globe?

    The global GMP cytokines market growth is mainly attributed to factors such as increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

    Who are the major players in the GMP cytokines market?

    The GMP cytokines market majorly consists of the players such as Miltenyi Biotec, Sino Biological, Inc., ABCAM, PeproTech, Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group, Inc., and REPROCELL Inc. among others.

    The List of Companies - GMP Cytokines Market

    1. Miltenyi Biotec
    2. Sino Biological Inc.
    3. ABCAM
    4. PeproTech Inc.
    5. Akron Biotech
    6. CellGenix GmbH
    7. BIO-TECHNE CORPORATION
    8. CREATIVE BIOARRAY
    9. Proteintech Group Inc.
    10. REPROCELL Inc

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports